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BACKGROUND OF THE INVENTION

Field of the Invention
The present invention is directed generally to methods and associated materials for analysis of the effect and operation of invasive Stimuli upon animal hosts, and in particular, is concerned with the mechanism and magnitude of the effect that Such invasive Stimuli may exert upon the activity of anabolic enzymes present in the host.
2. Description of the Prior Art Several common physiological and biochemical derange ment have been Seen in various mammalian hosts respond ing to variety of invasive Stimuli Such as bacterial, Viral and protozoan infections, as well as tumors and endotoxemia. For example, these responses include fever, leukocytosis, hyperlipidemia, reduced food intake and activity, and other In accordance with a first aspect of the present invention, a method for preparing a mediator Substance for use in assessing the State of anabolic enzymes in mammals, is disclosed, whichfinds particular utility in the instance where the mammals areundergoing invasive Stimuli Such as, Viral agents, bacteria, protozoa, tumors, endotoxemia and others. In its Simplest aspect, the method comprises gathering a Sample of macrophage cells from amammal and incubating a portion of the macrophage cells with astimulator material asSociated with an invasive event. Forexample, the Stimu lator material may be endotoxin, in the instanceof endotoxemia, trypanoSomes, in the instance of the above mentioned protozoan parasite TrypanoSoma brucei, and others.
While the peritoneal exudate cells illustrated in our present and previous applications exemplify Sources for themacrophage cells, it is to be understood that Such cells may begathered from other than the peritoneal area, and that the present invention contemplates Such variation within its Scope.
The macrophage cells and the Stimulator material are incubated as indicated, and thereafter, the macrophage cells are induced to produce a mediator Substance capable of Supressing theactivity of the anabolic enzymes. Preferably, the inducement ofmediator production is accomplished dur ing the incubation periodwhich may, for example, extend up to about 20 hours. The resulting medium may be appropri Metcalf and C. F. Fox (Academi Press, New York), pp. 25-35 (1978) . Naturally, other cellular systems may be utilized in the instance wherespecific activities may be appropriately observed, and the invention is not limited to the Specific cellular Systems Set forth herein.
The invention includes methods for detecting the presence of Samples of the various invasive Stimuli in mammals by measuring mediator Substance activity in the mammals. Thus, a number of mediatorSubstances may be prepared from the incubation of individual cell samples with known Stimulator materials, and these mediator Samples may there after be used to raise antibodies capable of Specifically detecting the presence of the respective mediator Substance. These antibodies may be prepared by known techniques, includingthe well known hybridoma technique for example, with fused mouseSpleen lymphocytes and myeloma, or by development in various animals. Such as rabbits, goats and other mammals. The known mediator Samples and their antibodies may be appropriately labelled and utilized to test for the presence of the mediator Substance in, for example, Serum, as one may measure the degree of infection, and determine whether infection is increasing or abating, by observing the activity of the mediator Substance therein. A variety of well known immunological techniques may be utilized in accordance with this aspect of the present A further embodiment of the present invention relates to a method for preventing the occurrence of Shock in mammals,comprising detecting the presence and Shock pro moting activity ofa mediator Substance in the mammal, and thereafter administeringan antibody to the mediator Substance, in an amount effective toprevent the development of shock in the mammal.
The invention particularly relates to a method of treating Shock in humans, comprising administering to a human a Shock-reducing amount of an antibody Specific to a mediator Substance. Also, an assay System is disclosed and may be prepared for the Screening of drugs potentially effective to inhibit theSynthesis or activity of the mediator Substance. In the former instance, the effect of the test drug on the production of mediator by Stimulated macrophages is determined, In the latter instance,a mediator Substance may be introduced to cellular test systems, such as the 3T3 L1 cells, and the prospective drug may then be introduced to the resulting cell culture and the culture thereafter examined to observe any changes in mediator activity, either from the addition of the prospective drug alone, or the effect ofadded quantities of the known mediator Substance.
A number of materials, compounds and agents have already been tested to determine their effect if any on mediator Substanceproduction and activity. AS discussed in further detail in thedescription, infra., only the Steroid dex amethasone exhibited any inhibitory effect, and that effect appeared to be limited to theproduction of the mediator Substance. Further agents, drugs, etc. can however be tested in the manner Such as that employed withdexamethasone, and described herein.
The preparation of the mediator Substance, and the deter mination of the importance of its activity, has resulted in the development of numerous avenues of diagnostic and thera peutic application. It is clear from the foregoing and following, that the detection of invasive Stimuli may be made by the identification of the mediator substance, either directly or through the development of antibodies useful in immunological diagnosis. Further, these same antibodies may be utilized for direct treatment by control of mediator activity, to avert the development of Shock in mammals, while the mediator Substance may be utilized as Screening agents in an assay System for the identification ofdrugs, agents and other Substance (capable of neutralizing thead verse effects of the mediator Substance, and thereby provid ing treatment of the adverse Sequelae of infection.
Accordingly, it is a principal object of the present inven tion to provide a method for the preparation of a mediator Substance exhibiting Suppressive effects upon anabolic enzyme activity in mammals.
It is a further object of the present invention to provide a method for detecting the presence of a mediator Substance in mammals in which invasive Stimuli Such as infection are
Suspected to be present.
It is a further object of the present invention to provide a method and associated assay System, for Screening Sub stance Such as drugs, agents and the like, potentially effec tive incombating the adverse effects of the mediator Sub stances in mammals.
It is a yet further object of the present invention to provide a method for the treatment of mammals to control the US 6,419,927 B1 S activity of Said mediator Substance So as to mitigate or avert the adverse consequences of their activity.
Other objects and advantages will become apparent to those skilled in the art from a review of the ensuing description, which proceeds with reference to the following illustrativedrawings DESCRIPTION FIGS. 11A and 11B show the dose dependent effect of the endotoxin-stimulated macrophage mediator on cell growth and erythroid differentiation of MeSO-treated Friend cells. Cells were incubated for 96 hours in the presence of 1.5% MeSO with increasing concentrations of the macrophage mediator. ASSays of enzymes andintermediates were per formed as described in Example III, infra. Data are the mean of duplicate determinations. Friend cells were incubated for 96 hours without changing the medium. MeSO was added at time 0 to a final concen tration of 1.5 vol %, while the endotoxin-stimulated mac rophage mediator was added at the times indicated on theabscissa (80 ul conditioned medium per ml of growth medium). Cell number, activities of ALA dehydratase and PBG deaminase, heme and protoporphyrin contents were assayed at the end of incubationas described in Example III, infra. Data are the mean of duplicatedeterminations. During the initial work wherein the foregoing observa tions were made, the method for preparing the mediator was developed, and an illustrative preparation is Set forth ini tially in Example I, in paragraph D, wherein peritoneal exudate cells were appropriately cultured and thereafter incubated in the presence of the known Stimulator material endotoxin. After incubation, the macrophage cells are induced to produce the mediator Substance. In one aspect, Such inducement can occur over aneXtended incubation, i.e.
on the order of 20 hours or more. The exact period for such incubation, however, may vary, and theinvention is not limited to a specific time period.
Thereafter, the mediator substance may be recovered from the cell culture and Stored for later use in one or more of theways disclosed herein. Recovery may be effected by one of numerous well known techniques, including centrifuga tion and precipitation. For example, the culture described in paragraph D of Example I, was centrifuged and the Super natant thereafter drawnoff. Alternately, the mediator may be precipitated either witha 40-60% solution of ammonium sulfate or by adsorption onto DEAE cellulose or like eXchange resins. The choice of the particularmethod for recovery of the mediator substance is within the skillof the art.
The invention also relates to methods for detecting the presence of invasive Stimuli in mammalian hosts by mea Suring thepresence and activity of the mediator Substance.
AS mentioned earlier, the mediator Substance can be used to produce antibodies to themselves in rabbits, goats, sheep, chickens or other mammals, by a variety of known techniques, including the hybridoma technique utilizing, for example, fused mouse Spleenlymphocytes and myeloma cells. The antibody can be isolated byStandard techniques and utilized as a test for the presence ofthe mediator Sub stance in the Suspected mammalian hosts.
Further, the antibody or antibodies can be utilized in another species as though they were antigens, to raise further antibodies. Both types of antibodies can be used to deter mine the presence of mediator Substance activity in the mammalianbody, particularly in human Serum, So as to determine the presenceof invasive Stimuli Such as bacterial, Viral, or protozoan infection, or the presence of certain tumors, and to follow the course of the disease. For purposes of the following explanation, theantibody or antibodies to mediator activity, will be referred toas Ab the antibody or antibodies raised in another Species will be identified as Aba.
The presence of mediator Substance activity(ies) in the Serum of patients Suspected of harboring toxic levels thereof can be ascertained by the usual immunological procedures applicable toSuch determinations. A number of useful pro cedures are known.Three Such procedures which are espe cially useful utilize eithermediator labeled with a detectable label, antibody Ab labeled with a detectable label, or antibody Ablabeled with a detectable label. The procedures may be Summarized by the following equations wherein the asterisk indicates that the particle is labeled, and "Med" Stands for mediator activity:
A. Med+Ab=Med Ab B. Med--Ab*=MedAb*
The procedures and their application are all familiar to those skilled in the art and accordingly may be utilized interchangeably within the Scope of the present invention. The "competitive" procedure, Procedure A, is described in US 6,419,927 B1 9 U.S. Pat. Nos. 3, 654, 090 and 3, 850, 752 . Procedure C, the "sandwich' procedure, is described in U.S. Pat. Nos. RE 31,006 and 4,016,043. Still other procedures are known such as the "double antibody", or "DASP" procedure.
In each instance the mediator Substance forms a complex with one or more antibody(ies) and that one member of the complexis labeled with a detectable label. The fact that a complex hasformed and, if desired, the amount thereof, can be determined by known methods applicable to the detection of labels.
It will be seen from the above, that a characteristic property of Ab is that it will react with Ab. This is because Ab raised in one mammalian Species has been used in another species as an antigen to raise the antibody Aba. For example, Ab may be raised in rabbits using a mediator as the antigen and Ab may be raised in goats using Ab as an antigen. Ab therefore would be an anti-rabbit antibody raised in goats. For purposes of thisdescription and claims, Ab will be referred to as a mediator activity antibody and Ab will be referred to as an antibody reactive with a mediator activity antibody or, in the alternative, an "anti antibody". The labels most commonly employed for these Studies are radioactive elements, enzymes, chemicals which fluoresce wheneXposed to ultraViolet light, and others.
A number of fluorescent materials are known and can be utilized as labels. These include, for example fluorescein, rhodamine and auramine. A preferred detecting material is anti-rabbit antibody prepared in goats and conjugated with fluorescein throughan isothiocyanate.
The mediator composition(s) can also be labeled with a radioactive element or with an enzyme. The radioactive label can be detected by any of the currently available counting procedures. The preferred isotope 'C, "I, H, 'I and S. The enzyme label can be detected by any of the presently utilized calorimetric spectrophotometric, fluo rospectrophotometric or gasometric techniques. The enzyme is conjugated to the Selected particle by reaction with bridging molecules Such as carbodiimides, diisocyanates, glutaraldehyde and the like. Many enzymes which can be used in these procedures are known and can be utilized. The preferred are peroxidase, B-glucuronidase, B-D-glucosidase, B-D-galactosidase, urease, glucose oxidase plus peroxidase, galactose oxidase plus peroxidase and acid phosphatase. U.S. Pat. Nos. 3, 654, 090; 3, 850, 752; 4, 016, 043; are referred to by way of example for their disclosure of alternate labeling material, and materialsHigh levels of mediator activity in the mammalian body may be toxic to the mammal and cause irreversible shock. Theantibody(ies) specific to a mediator is useful to treat hosts Suffering from this metabolic derangement. The patient can be treated for example, parenterally, with a shock-reducing, effective doseof the antibody to neutralize at least a portion of the mediator.The dose will, of course, vary in accordance with the factors wellknown and understood by the physician or veterinarian Such as age, weight, general health of the patient and the concentration of themediator.
In a further embodiment of this invention, commercial test kits Suitable for use by a medical Specialist may be prepared to determine the presence or absence of mediator Substances in a Suspected host. In accordance with the testing techniquesdiscussed above, one class of Such kits will contain at least the labeled mediator or its binding partner, an antibody Specificthereto. Another which contain at least Ab together with labeled Aba. Still another will contain at least Ab and directions, of course, depending upon the method Selected, e.g., "competitive", "Sandwich', In yet another aspect of the invention, antibodies specific to the aforementioned mediator may be administered in pharmaceutical compositions in response to shock produced by Viruses, bacteria, protozoa, etc. These pharmaceutical compositions comprise: AS an adjunct to the development of antibodies and their use in the techniques described above, the present invention extends to methods of treatment of various conditions, Such as shock etc., that are found to exist as a result of undesirably high mediator Substance activity in the mammalian host. In Such instance, the method of treatment may include the detection of the presence and activity of the particular mediator Substance, and the Subsequent administration of the appropriate antibody or antibodies to the host, in amounts effective to neutralize the undesired mediator Substance activity.
Conversely, certain adverse conditions in mammals. Such a obesity, may result from exceSS anabolic activity. For example, obesity may be caused by undesirably high levels of activity of the anabolic enzymes lipoprotein lipase, acetyl Coenzyme A carboxylase and fatty acid Synthease. The invention accordingly includes a method for treating obesity, comprising administering a mediator Substance in an accept able form, and in an amount effective to assist in restoring proper body weight. Administration of Such treatment, however, would be under Strict control by a physician, and the amount, manner and frequency of administration of the mediator would be carefully determined and constantly monitored.
In addition to treatment with antibodies raised by a mediator Substance, the present invention includes an assay System, for the examination of potential Substances, Such as drugs, agents, etc. to inhibit the Synthesis or activity of a mediator Substance. AS described earlier appropriate cell 11 cultures Such as the 3T3-L1 and the Friend virus trans formed erythroleukemia cells may be initially treated with a particular mediator to inhibit the activity of a particular anabolic actor, after which the potential drug etc. may be added, and the resulting cell culture observed to determine whether changes in the activity of the anabolic actor have taken place. While the foregoing description makes reference to Specific cell cultures for thepresent assay, it is to be understood that the invention is not limited thereto.
Certain compounds have already been Screened, to deter mine whether or not each inhibited mediator production and/or the effect of the mediator. Compounds tested and the results of such tests are set forth in the table, below. AS can be seen, only dexamethasone seems to have any effect. And even dexamethasone only has an effect on "mediator" production and, thus, is only effective at the beginning of the process. Once the mediator has been produced, the dexamethasone does not seem tohave any further impact.
The following examples relate to the isolation of the mediator Substance, and the observation of its activity, as related to certain anabolic enzymes etc. A review of the following should lend greater appreciation to the origins and potentials of the present invention. Naturally, however, the Specific materials and techniques may vary, as explained earlier, So that the following is presented as illustrative, but not restrictive of the present invention.
It should be noted that the terms "mediator" and "media tor Substance', whether used in the Singular or in the plural, are intended to refer to the same material that is isolated from macrophage cells that have been incubated with a Stimulator material as disclosed herein, and both Singular and plural usages of these terms, where present, should be Viewed as equivalent for purposes of the present disclosure. At present, the exact composition of the mediator is unknown and, therefore, also unknown is whether the mediator is a Single material or a mixture. Accordingly, the present terminology is intended to cover the "mediator" whether it is a Single material or a mixture of materials. The term "mediator activity composition' and its plural may be distinct, as, although the mediator or mediator Substance would be the Same, the remainder of the composition may possibly vary depending upon the degree to which other cellular constituents, factors, etc. may be present therein. Male C3H/HeN endotoxin sensitive mice (7-10 wk: 18-25 g) were obtained from Charles River Breeding Labo ratory (Wilmington, Mass.). Male C3H/Hej, endotoxin resistant mice (7-10 wk: 18-25 g) were obtained from The Jackson Laboratory (Bar Harbor, Me...). Mice were fed ad libitum on Rodent Laboratory Chow (Ralston Purina Co., St. Louis, Mo.) until they were utilized. 
D. Preparation of Endotoxin Treated Peritoneal Exudative
Cells:
Peritoneal exudate cells were obtained by peritoneal lav age with pyrogen-free Saline (Abbott Laboratories, North Chicago, Ill.) from C3H/HeN mice (25-33 g). These mice were injected imp 6 days prior to lavage with 3 ml of Sterile 13 Brewer's thioglycollate medium (Difco Laboratories, Detroit, Mich.) to increase cell production. The peritoneal exudate cells obtainedby this procedure consist of approxi mately 60% macrophages, 20% small lymphocytes, 15% large lymphocytes, and 5% eosinophils.
The exudate cells (2x10 cells/well) were incubated in serum-free RPMI-1640 medium (Gibco, Grand Island, N.Y.) in culture plates containing 4.5 cm wells at 37° C. in 5% CO. After 3 hours, the cultures were washed three times with the medium to remove nonadherent cells. The cells which adhered to the dishwere mainly macrophages. In the various testing procedures, thecells were incubated in serum-free RPMI-1640 medium in the presence or absence of endotoxin (10 ug/ml). The culture medium was removed at 26 hours incubation and centrifuged at 1000 g for 5 minutes at 4 C. The Supernatant was used for testing immediately or kept at -80 C. until required for testing. No difference in activity was noted after Storage for one month under these conditions.
The various studies and isolation procedures will now be described.
E. Mediator Activity Produced in Mice:
The LPL activity from adipose tissue and the serum triglyceride concentration offendotoxin-Sensitive mice which had been injected with eithersaline (controls or 100 ug of endotoxin) 16 hours before sacrifice was observed. This amount of endotoxin corresponds in this Strainof mice to a dose in which half the animals die within three daysafter injection. It was observed that the LPL activity of adiposetis Sue in the endotoxin-treated animals was depressed to 4.5% of the control values while the triglyceride concentration in theserum of the endotoxin treated animals were elevated 2.6 times that of control animals.
The fact that the lowering of LPL activity is to be attributed to mediator activity produced as a result of Stimulation by endotoxin and not to the endotoxin itself is supported by the results obtained when the serum from endotoxin-sensitivemice which had been treated with 100 lug of endotoxin 2 hours prior to bleeding was injected into another group of endotoxin-Sensitive mice. For this test, the control group was injected with Serum obtained from another group of endotoxin-sensitivemice which had been injected with pyrogen-free Saline. LPLactivity in epididymal fat pads were measured 16 hours later.
AS further illustrated in FIG. 1A , the serum from endotoxin-treated mice markedly Suppressed LPL activity in these animals compared to the activity in the control group of animals. Since greater than 90% of endotoxin is known to be cleared from circulation in 15 minutes, it is clear that the observed effect on LPL activity is not due to a direct effect on any remaining endotoxin present in the Serum 2 hours after injection. It must be caused by a humoral factor or mediator produced as a result of the endotoxin injection.
To further exclude direct endotoxin effects, serum Experiments were undertaken to show that exudate cells could be stimulated to produce the mediator by which endotoxinsuppresses the LPL activity of adipose tissue.
Exudate cells were obtained from endotoxin-sensitive (C3H/ HeN) mice by peritoneal lavage. These cells were incubated in vitro in the presence of 10 ug/ml or absence of endotoxin. One ml of the media from these cell cultures was injected into the endotoxin-resistant strain ofC3H/He mice. As displayed in FIG. 2 Culture medium is collected from mouse peritoneal eXu date cells cultured in RPMI-1640 growth medium exposed to 10 tug/ml of endotoxin for 24 to 36 hours and centrifuged at 500 rpm for 10 minutes at 4 C. The Supernatant is subjected to ultrafiltration through an Amicon PM-10 mem brane with a 10,000-Dalton cut-off. The volume of the retentate is concentrated by filtration to approximately 7 ml, placed on a Sephacryl 300 column (1.695 cm) and eluted with phosphate-buffered saline (PBS) (pH 7.4) at 4 ml/hr and 4 C. The volume of each collected fraction was 3.6 ml.
The fractions were analyzed for LPL activity. Fractions eluting at 108 to 115 ml and 133 to 140 ml were found to be active in the LPL assay. The molecular weights of the mediatoractive compositions in these fractions are about 300,000 and 70,000 Daltons, respectively.
The lyophylized filtrate from the ultrafiltration is dis Solved in a minimal amount of distilled water, chromato graphed on a Sephadex G 50 column (1.6x95 cm), and eluted with PBS (pH 7.4) at a flow rate of 6 ml/hr. Fractions of 3 ml were collected and analyzed for LPL activity. The activity was located in fractionseluting at 170 to 179 ml which corresponds to a molecular weight to about 400 to 1,000 Daltons.
The approximate molecular weights were determined in accordance with Standard practice by comparison with pro teins of known molecular weight. The Standards employed were ferritin, molecularweight-440,000 Daltons; bovine serum albumin, molecular weight-68,000; carbonic anhydrase, molecular weight-30,000; and ribonuclease, molecular weight-17,000; all in Daltons. As is known to those skilled in the art, molecular weights determined by thisprocedure are accurate to about 20%.
Mediator activity compositions can also be isolated from mouse peritoneal exudate cells by Vacuum dialysis using a according to the following procedure.
Vacuum dialysis was carried out in dialysis tubing with molecular weight cut-offs at 13,000-14,000 Daltons. Samples of conditioned medium obtained from endotoxin treated exudate cell cultures were placed under vacuum for 6 hours at 4 C. with a 40-percent reduction in volume. Aliquots from inside and outside the bag were assayed for mediator activity.
It was found that all of the activity was retained during vacuum dialysis with membranes having a 12,000-Dalton pore cutoff. The mediator composition isolated by this procedure, therefore, has a molecular weight greater than 12,000 Daltons. This composition contains the two higher molecular weight compositions previously described. The reason that the lowest molecular weight composition is not obtained is not clear. Possibly because it is absorbed in the Millex membrane or because the procedure with the Amicon filter is more rapid.
The stability of the various mediator compositions to heat was assessed by heating at 100° C. for 15 minutes. The inhibitory effect of the mediators on the lipoprotein lipase was completely abolished by this treatment.
To determine whether the mediators are intracellular constituents of nontreated cells, exudate cells were Sonicated and the extract was assayed for mediator activity. These extracts had no measurable mediator. The mediators, therefore, are not a normal intracellular Substance of exudate cells, but are Synthesized or processed in these cells follow ing Stimulation by endotoxin.
The fact that the mediator activity compositions are in the tissue culture medium of tissue cultures of peritoneal eXu date cells make it clear that they are water-Soluble.
The mediators, therefore, are capable of reducing LPL activity in the mammalian body, can be isolated by Standard procedures Such as chromatography, dialysis and gel elec trophoresis from the Serum of endotoxin-treated animals or from a cell culture of peritoneal exudate cells incubated with endotoxin.
H. Studies of 3T3-L1 Preadipocytes:
The properties of the mediator compositions were further investigated using the well defined 3T3-L1 "preadipocyte" model System, by the inventors herein and co-workers, P. Pekala and M. D. Lane, 3T3-L1 preadipocytes, originally cloned from mouse embryo fibroblasts, differentiate in monolayer culture into cells having the biochemical and morphological characteristics of adipocytes. During adipo cyte conversion, 3T3-L1 cells exhibit a coordinate rise in the enzyme of de novo fatty acid Synthesis and triacylglycerol Synthesis. Similarly, the activity of lipoprotein lipase, another key enzyme of lipid metabolism, rises 80-180 fold during adipose conversion. The activity of the enzyme is enhanced by the presence of insulin in the medium and appears to be similar to the lipoprotein lipase of adipose tissue.
Utilizing cells of the 3T3-L1 preadipocyte cell line, it was found that addition of the mediator compositions, derived from mouse peritoneal exudate cells exposed to endotoxin as described above, Suppresses the activity of lipoprotein lipase.
The endotoxin used in the 3T3-L1 cell culture study was 7570-7578 (1978) ). Two days after confluence, the medium was Supplemented with 0.5 mM isobutyl-methylxanthine, 1 uM dexamethasone and 10 tug of insulin per ml. Forty-eight hours later, the medium containing isobutyl-methylxanthine, dexamethasone, and insulin was withdrawn and replaced with medium contain ing insulin at a reduced concentration of 50 ng per ml.
J. Effect of Mediator Compositions on 3T3-L1 Cells:
One hour after the culture medium was replaced with medium containing the reduced concentration of insulin, conditioned media from cultured exudate cells with or without added endotoxin were added to 3T3-L1 cell cul tures. Incubation of the cells with the conditioned medium was carried out for up to 20 hours. At indicated times, the amount of lipoprotein lipase activity was measured in three compartments: (1) the activity of the medium; (2) the activity released from the cells following incubation with heparin (this activity represents the enzyme associated with the outer surface of the cell membrane); and (3) intracellular activity.
Following the withdrawal of the medium, the dishes were rinsed once with fresh medium and the lipoprotein lipase asSociated with the cell membrane was released by incuba tion for one hour in DME medium supplemented with heparin (10 U/ml) and insulin (50 ng/ml). After removing this medium, the dishes were rinsed with PBS and the cells were scraped into 1 ml of 50 mM, NH/NHC1 buffer, pH 8.1 containing heparin 3 U/ml. The cell Suspension was Sonicated (on ice) for 15 Seconds and centrifuged at 500xg for 5 minutes. The Supernatant was assayed for lipoprotein lipase.
Lipoprotein lipase assays were performed within 30 min utes after the preparation of each Sample in duplicate by the method of Nilsson-Ehle and Shotz, J. LIPID. RES. 17 at 536-541 (1976) with minor modifications. Briefly, 75ul of enzyme was mixed with 25 ul of Substrate containing 22.7 mM3H-triolein (1.4 uCi per mole), 2.5 mg per ml of lecithin, 40 mg per ml bovine serum albumin, 33% (V/V) human serum and 33% (V/V) glycerol in 0.27 M Tris-HC1, pH 8.1, and incubated at 37 C. for 90 minutes. One milliunit of enzyme activity was defined as the release of one nano mole of fatty acid per minute. The lipase activity in all three compartments was inhibited >90% by addition of 1M NaCl and >80% by omission of serum which is the source of apolipoprotein C-II needed for enzymatic activity.
To test the effect of the mediator on the lipoprotein lipase activity of 3T3-L1 cells, the conditioned medium obtained from mouse peritoneal exudate cells cultured in the presence or absence of endotoxin, was added to 3T3-L1 cells in monolayer culture. After a 20-hour incubation at 37 C., lipoprotein lipase activity was assessed in three compart ments: (1) the culture medium; (2) the cell Surface (heparin releasable lipase activity) and; (3) the intracellular fraction. The medium from the culture of exudate cells not treated with endotoxin had little effect on the lipoprotein lipase activity of 3T3-L1 cells. While the medium from untreated exudate cells elicited some inhibition in the study shown in  FIG. 3 , Col.B in other similar studies, medium prepared identically had no inhibitory effect. Endotoxin itself also had a negligible inhibitory effect on lipoprotein lipase activity when the amount added was equivalent to that which might remain in the conditioned medium from endotoxin-treated exudate cells; a 19%, 9%, and 0% decrease was observed on medium, heparin-releasable and intracellular compartments, respectively. The decrease was greater (45% in medium, 17% in heparin-releasable, and 11% in the cells) when larger amounts (4.5 times) of endotoxin was employed, as shown
A possible explanation for the decreased activity of lipo protein lipase described above is a direct inhibitory effect of mediators on the enzyme. This was examined by incubating medium from 3T3-L1 cell cultures which contained lipo protein lipase with conditioned medium from cultures of endotoxin-treated exudate cells. It was found that the enzyme activity was not inhibited by the mediator compo sitions (103% of the control) at the time of mixing, and the rate of decay of enzyme activity was the same in the experimental group and the control group. Endotoxin also had no effect on the activity of lipoprotein lipase. The results imply that the mediator compositions depress lipoprotein lipase activity in 3T3-L1 cells by inhibiting the intracellular Synthesis or processing of the enzyme.
The relationship between the amount of mediator com positions and lipoprotein lipase activity of 3T3-L1 cells was examined by incubating the cells with increasing amounts of the conditioned medium from endotoxin-treated exudate cells for 20 hours at 37 C. Ten ul of conditioned media added to 1.5 ml of culture media was Sufficient to cause a Substantial decrease in lipoprotein lipase activity, i.e., 57% decrease in the medium, 40% decrease in the heparin releasable compartment, and 8% decrease in the cells. Enzyme activity was further depressed by increasing the amount of mediator containing medium. When 250 ul were added, a decrease of greater than 95% was observed in all three compartments. The amount of mediator present in conditioned medium varied Somewhat from preparation to preparation.
The rate at which lipoprotein lipase activity declines after the addition of the mediators was also investigated. Condi tioned medium containing mediators was added at Selected intervals, and lipoprotein lipase activity was measured. A reduction of lipase activity was apparent as early as 30 minutes after addition of 3T3-L1 cells. Approximately half of the intracellular enzyme activity was lost after 2.5 hours.
After 5 hours of incubation with a mediator, a maximal effect was observed. The amount of enzyme activity in the medium and that on the cell Surface were also observed to decrease with a similar time course (data not shown). 
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The rapid decrease in lipoprotein lipase activity might reflect a competition with insulin Since removal of insulin has been shown to lead to a rapid decline in lipoprotein lipase activity in 3T3-L1 cells. However, an attempt was made to reverse the Suppressive effect of the mediator by increasing the concentration of insulin in the medium was not Successful. For this study, the effect of incubating 3T3-L1 cells with media containing insulin at various con centrations (50 ng/ml to 50 ug/ml) and mediator was assessed for lipoprotein lipase activity. It was found that the inhibitory effect of the mediator on enzyme activity was not changed with increasing insulin concentrations. Even at an insulin concentration 1,000 greater (50 ug/ml) than that of standard onditions (50 ng/ml), the inhibition was not reversed.
EXAMPLE II
Reasoning that other anabolic activities of the 3T3-L1 cells might be inhibited by the mediator, we studied two key enzymes: (1) acetyl CoA carboxylase; and (2) (1978) . Two days after confluence, the medium was supplemented with 0.5 mM isobutyl-methylxanthine, 1 uM dexamethasone and 10 ug of insulin per ml. Forty-eight hours later, the medium contain ing isobutyl-methylxanthine, dexamethasone, and insulin was withdrawn and replaced with medium containing insu lin at a reduced concentration of 50 ng per ml.
C. Preparation of Peritoneal Exudative Cells and Mediator
Substances:
Peritoneal exudate cells were obtained by peritoneal lav age from C3H/HeN mice (25-33 g; Charles River Breeding Laboratories, Wilmington, Mass.) which had been injected intraperitoneally with sterile Brewers thioglycollate 19 medium (Difco Laboratories, Detroit, Mich.; 3 ml per mouse) 6 days prior to harvest. The exudate cells obtained using this procedure are primarily macrophages with Some contaminating lymphocytes, The cells (4x10 cells per cm) were incubated in serum free RPMI-1640 medium for 3 hours after which nonadher ent cells were removed by washing 3 times with medium. Cells adhering to the dish were primarily macrophages.
These cells were further incubated in serum-free RPMI 1640 medium in the presence or absence of 10 ug per ml of endotoxin. After 24 hours, the culture medium was removed and centrifuged at 1,000xg for 5 minutes at 4 C. The Supernatant of conditioned medium obtained from cells exposed to endotoxin was assayed and found to contain the mediator Substance that lowers LPL in 3T3-L1 cells.
No difference in activity was noted after storage of the conditioned medium for one month at -80 C. D. Effect of Mediator on 3T3-L1 Cells:
One hour after the culture medium was replaced with medium containing the reduced concentration of insulin, conditioned media from cultured exudate cells with or without added endotoxin were added to 3T3-L1 cell cul tures. Incubation of the cells with the conditioned medium was carried out for up to 20 hours. E. Labeling of Cellular Proteins:
A 6-cm plate containing induced 3T3-L1 cells was washed twice with 5 ml of methionine-free medium and incubated for 1 hour with 2 ml of the same medium containing 0.5 mCi of L-S-methionine during which period the rate of S-methionine incorporation into cel lular protein was linear. The medium was removed, the cell monolayer washed twice with phosphate-buffered Saline, ph 7.4, and the Soluble cytosolic proteins released by the digitonin method of Mackall, et al., Supra. The remainder of the cell monolayer containing the membranous fraction was then scraped into 2.0 ml of 100 mM HEPES buffer, pH 7.5, containing 0.5% of the nonionic detergent NP-40 and 1 mM phenylmethylsulfonylfluoride. After trituration in a Pasteur pipet, the Suspension was centrifuged at 10,000xg for 10 minutes at 4 C., and the Supernatant saved.
S-methionine incorporation into acid insoluble mate rial was determined by adding 20 ul of digitonin or NP-40 released material to 0.5 ml of ice cold 20% TCA with 25 ul of 0.5% bovine serum albumin added as carrier. After sitting at 4 C. for 1 hour, the mixture was centrifuged at 2,000xg for 5 minutes. The pellet was incubated in 0. 
H. Effect of Mediator on Protein Synthesis in General:
The observed effect on acetyl CoA carboxylase and fatty acid Synthetase could be explained by a general inhibition of protein Synthesis by the mediator. To examine this possibility, the effect of mediator on amino acid incorpora tion into protein was investigated. 3T3-L1 cells were incu bated for various periods of time with conditioned medium obtained from mouse peritoneal exudate cells cultured in the presence of endotoxin. S-methionine incorporation into Soluble and membrane associated protein was determined after 1, 3, and 6 hours of exposure of the cells to the added factor. When 3T3-L1 cells were exposed to conditioned medium from mouse peritoneal exudate cells that were cultured in the absence of endotoxin, no effect on S The loss of a protein band with molecular weight 220,000 in the digitonin releasable protein, is consistent with the loSS of immunoadsorbable acetyl CoA carboxylase and fatty acid Synthetase. The enzymes have Similar molecular weights and under the conditions of this electrophoresis migrate with the Same Rim. At present, it is not possible to identify the other protein bands with known enzymes or proteins. I. Analysis.
The mediator appears to decrease enzymatic activity by Suppressing the Synthesis of the enzymes. The effect on protein Synthesis appears to be quite Specific as there are no grOSS perturbations of the protein patterns observed on the autoradiograms (FIGS. No. 8 and 9) . In response to the mediator, the Synthesis of Several proteins is inhibited or induced. It was possible by immunoprecipitation to identify fatty acid synthetase and acetyl CoA carboxylase (M.W. 220,000) as two proteins whose synthesis is inhibited by the mediator. The identification of the other proteins that are modulated by the mediator is not possible at present, although lipoprotein lipase is a potential candidate for the 50,000-Dalton protein that appears. The nature of proteins that are induced in response to the mediator and the mecha nism for the modulation of Specific protein Synthesis are deserving of further improvement investigations.
Whether the mediator responsible for regulating the syn thesis of acetyl CoA carboxylase and fatty acid Synthetase is the same as the mediator that Suppresses the activity of lipoprotein lipase is not presently known. The relationship of these mediator(s) to the leukocyte factor that has been reported to metabolize amino acids from muscle to the liver is of considerable interest since this factor also imparts a catabolic State on the tissue.
EXAMPLE III
In this Series of investigations, also embodied in an unpublished manuscript in preparation by the inventors herein, and co-worker Shigeru Sassa, we Sought to deter mine whether the macrophage mediator(s) observed in Examples I and II exerted any effect upon red blood cell Synthesis. We reasoned that, as anemia is commonly observed in mammals afflicted with chronic infections, and that as regeneration of the red cell mass constitutes a potential drain on energy and amino acids, the body in response to acute invasion may interrupt erythroid develop ment in Similar fashion and perhaps by the same mechanism observed with respect to the anabolic enzymes lipoprotein lipase, acetyl Coenzyme A carboxylase and fatty acid Synthetase, that affect adipocytes.
To evaluate this hypothesis, we examined the effects of endotoxin-induced factor(s) from mouse macrophages on Endotoxin (lipopolysaccharide) from E coli 0127. B8 isolated by the method of Westpal (described supra), was purchased from Difco (Detroit, Mich.). A modified F12 medium was prepared in our laboratory (Sassa, S. et al., J. BIOL. CHEM. 252: 2428 -2436 (1977 ). Fetal bovine serum was purchased from GIBCO (Grand Island , 142:1150-1164 (1975) ).
These cells were further incubated in the serum-free medium in the presence of endotoxin (5 ug/ml) for 24 hours.
After incubation, the culture medium was removed and centrifuged at 1000xg for 5 minutes at 4 C. The Supernatant of the conditioned medium contained an endotoxin-induced mediator which decreased the activity of lipoprotein lipase in 3T3-L1 cells (as reported in Example I, above) and was used without further treatment.
D. Induction of Erythroid Differentiation:
Two types of incubation protocols were used to assess erythroid differentiation of Friend cells. In certain experi ments illustrated in FIGS. 10-13, the cells (5x10" cells/ml) were incubated at 37° C., in 5% CO in humidified air for 18 hours. The inducing chemicals, e.g. MeSO, HMBA, butyric acid, hypoxanthine or hemin were added with or without macrophage mediator(s) and cultures were incubated for 96 hours without changing the growth medium. In other experi ments Such as those with results illustrated in FIG. 14, the cells (10 cells/ml) were incubated for 18 hours, then MeSO and the macrophage mediator were added as above.
The cultures were maintained at 2x10 cells/ml by diluting the cell Suspension daily with fresh medium containing the chemical inducer with or without the macrophage mediator. This procedure required more macrophage mediator than the first experimental procedure, but made it possible to exam ine the effect of mediator on rate of cell growth while cells were growing logarithmically at a constant rate (Chang, C. S. et al; J. BIOL. CHEM. 257:3650-3654 (1982) (Sassa, S. Granick, J. L., Eisen, H., and Ostertag, W., Supra.). ASSays of aminolevulinic acid (ALA) dehydratase and porphobilinogen (PBG) deaminase were carried out by methods described previously (Sassa, S., Granick, J. H., Eisen, H., and Ostertag, W., Supra.). (FIG. 10, Part A. ). When these cells were incubated simultaneously with 1.5% MeSO, control conditioned medium which had not been exposed to endotoxin inhibited the cell growth by ~.42% When Friend cells were incubated simultaneously with 1.5% MeSO and the endotoxin-stimulated macrophage mediator, the rate of cell growth was progressively inhibited when increasing amounts of the mediator were added to the culture (FIG. 11, Part A ). An inhibitory effect of the mediator on cell growth could be detected at the lowest concentration examined (1.12 vol. 9% added to growth medium), At the highest concentratio (8 vol. 9%), the mediator inhibited cell growth by ~60% compared with that of the control Me-SO treated culture (FIG.11, Part A) . The decrease in cell number (FIG. 11, Part B .) The enzymatic activities of ALA dehydratase and PBG deaminase were also decreased by the mediator treatment (FIG. 11, Part B) . The addition of the macrophage mediator directly to the enzyme assay mixture did not inhibit the activity of ALA dehy dratase or PBG Deaminase(data not shown), ruling out a direct inhibitory effect on the activities of the enzymes. When the endotoxin-stimulated conditioned medium was added to MeSO-treated cultures at various times, it was found that the effect of the macrophage mediator on cell growth was gradually lost (FIG. 12) .
The effect of the macrophage mediator on erythroid differentiation decreased more rapidly than the effect on cell growth. For example, the addition of the endotoxin Stimulated macrophage mediator inhibited heme and proto porphyrin formation by ~.40% at the beginning of incubation, ~25% when added at 24 hours, and had no effect when added at 48 hours or after. Inhibition of the activity of ALA dehydratase and PBG deaminase by the macrophage mediator treatment was also progressively diminished when the mediator was added later during incubation (FIG. 12) .
These findings indicate that, in contrast to the macrophage-mediator dependent inhibition of cell growth and differentiation observed in erythroid-committed cells, cells which have fully expressed erythroid characteristics Such as those exhibiting maximal increases in the activities of ALA dehydratase and PBG deaminase, or in the contents of protoporphyrin and heme, are considerably leSS Sensitive to the inhibitory effect of the macrophage mediator. I. Effects of the Endotoxin-Stimulated Macrophage Media tor on Erythroid Differentiation of Friend Cells Induced by HMBA, Butyric Acid, Hypoxanthine or Hemin:
In order to examine whether or not the inhibitory effect of the endotoxin-stimulated macrophage mediator on erythroid committed cells is specific for MeSO-induced differentiation, we examined the effect of the macrophage mediator on cells which were incubated with either HMBA, butyric acid, hypoxanthine or hemin. We found that the endotoxin-stimulated macrophage mediator markedly inhib ited the growth of cells incubated with HMBA, butyric acid or hypoxanthine, but not the growth of hemin-treated cells (FIG. 13, Part A) . Similarly, the endotoxin-stimulated mediator inhibited the erythroid differentiation induced by HMBA, butyric acid or hypoxanthine, but not that induced by hemin treatment (FIG. 13, Part B) .
These findings Suggest that the inhibitory action of the endotoxin-stimulated macrophage mediator on the growth of erythroid-committed cells and erythroid differentiation induced by most of the chemical agents as represented by MeSO, HMBA, butyric acid or hypoxanthine is similar, but that erythroid differentiation induced by hemin treatment is distinct in nature and not sensitive to the effect of the macrophage mediator. In fact the growth inhibition of MeSO-treated cells produced by the macrophage mediator alone (35%, FIG. 10 ) was completely overcome by hemin treatment (FIG. 13) . In order to examine the effect of the macrophage mediator on the growth of Friend cells while they are growing at a constant rate, cells were diluted with fresh medium with or without the mediator every 24 hours to reduce the cell density to 2x10 cells/ml. 
K. Analysis:
The mediator Substance under Study appears to potently inhibit the growth and erythroid differentiation of mouse Friend-virus transformed cells. Conditioned medium from cultures not exposed to endotoxin had Some inhibitory effects, but the effect of the endotoxin-stimulated condi tioned medium is significantly greater in inhibiting the growth and differentiation of Friend cells. Endotoxin itself had no effect on either cell growth or differentiation.
Further, the effect of the mediator appears to be specific to certain Stages of erythroid progenitor cells, in that the macrophage mediator inhibited the growth and erythroid These results indicate that the endotoxin-stimulated mac rophage mediator exerts its inhibitory effect on the growth and differentiation of cells of erythroid precursor cells including those which have been committed to undergo erythroid differentiation. On the other hand, cells which have fully expressed characteristics of erythroid cells Such as increased activities of ALA dehydratase and PBG deaminase, and increased contents of protoporphyrin and heme are no longer sensitive to the inhibitory effect of the conditioned medium. Thus it appears that the action of the endotoxin-stimulated conditioned medium is relatively spe cific to certain early Stages of erythroid precursor cells but not to fully differentiated erythroid cells.
We have also attempted to purify the mediator from the endotoxin-stimulated macrophage conditioned medium and found that a highly purified mediator retained the inhibitory property both on lipoprotein lipase activity in 3T3 cells and on the growth and differentiation of Friend cells.
The macrophage factor described in this Example is believed to play a role in the pathogenesis of the anemia asSociated with endotoxemia or other chronic disease States, e.g., cancer, rheumatoid arthritis, where the activity of the reticuloendothelia system is stimulated. The Friend cell system described here should be useful to detect such in vivo mediators and to elucidate the biochemical basis for the cellular effect of the mediator(s). This assay system should also aid the isolation of this factor and the identification of its relationship with other immune cell factors which are produced in response to invasion. Suffering from shock.
6. The method of claim 1 or 2 wherein the human is Suffering from cacbexia.
7. The method of claim 1 or 2 wherein the human is
Suffering from anemia associated with a chronic disease State. 8. The method of claim 7 wherein the chronic disease state is rheumatoid arthritis.
